Precision Business Insights


Digital Biomarkers Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

The Digital Biomarkers Market: By Products (Watches, Bands, wearable injectors, Textiles), By Application (Drug Discovery and Development, Personalised Medicine, Diagnosis, Others), By End-users (Hospitals, CRO, Research Laboratories, Diagnostic Centers), By Geography


Digital Biomarkers Market


Market Outline: Digital Biomarkers Market

Digital biomarkers give access to new kinds of experiences and offer exceptionally favorable circumstances by enabling information to be created much of the time and as a major aspect of the patient’s everyday life. Additionally, these minimal efforts, high-effectiveness apparatuses can be incorporated into existing biomarker techniques.


Market Dynamics: Digital Biomarkers Market 

The worldwide digital biomarkers market has seen expanded request as of late because of the quickly developing populace around the world, strong development of the IT business, and expanding endeavors toward tranquilize revelation. The section of new players is required to additionally support the development of the market. The developing utilization of digital biomarkers in therapeutic areas, for example, disease treatment and research will push the future development of the worldwide digital biomarkers market.  However, the requirement for high capital speculation, negative administrative and repayment approaches, high expenses of tests, test accumulation, and capacity, and low advantage cost proportion will limit the development of the digital biomarkers market.


Market Scope: Digital Biomarkers Market 

The Digital Biomarkers Market is classified on the basis of Products, application, end users, and geographical regions.

Based on Products, Digital Biomarkers Market is segmented into

  • Watches
  • Bands
  • wearable injectors
  • Textiles

Based on Application, Digital Biomarkers Market is segmented into

  • Drug Discovery and Development
  • Personalised Medicine
  • Diagnosis
  • Others

Based on End User, Digital Biomarkers Market is segmented into

  • Hospitals
  • CRO
  • Research Laboratories
  • Diagnostic Centers


North America

  • US
  • Canada


  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe


  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA


Market Summary: Digital Biomarkers Market 

The global digital biomarkers market is expected to grow with significant CAGR during forecast period. Market players are carrying out collaborations, partnerships, and acquisitions as key development strategies to enhance their sales revenue. In February 2018, Evidation Health launched  a 10,000 person chronic pain study, called the DisCover Project to quantify chronic pain and develop digital biomarkers for chronic pain severity, flare-ups and quality of life by using activity trackers, health apps, and other more traditional data points.


Regional Analysis: Digital Biomarkers Market 

Geographically Digital Biomarkers Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America rules the worldwide market of digital biomarkers market because of expanding the interest of maturing populace for diagnosis and treatment of age-related sicknesses. What’s more, higher appropriation rate of biomarkers advancements is likewise driving the development of biomarkers showcase in North America. Asia is relied upon to indicate high development rates in the following five years in worldwide digital biomarkers market. Factors driving the development of digital biomarkers market in developing markets of Asia are expanding innovative work action in India and China, expanding the number of agreements look into associations and ease for directing clinical trials.


Market participants: Digital Biomarkers Market 

Some of the players in Digital Biomarkers Market

  • The Hague I B.V. (Affymetrix Inc.) (Netherlands)
  • Abbott Laboratories (U.S.)
  • Hoffmann-La Roche Ltd. (Switzerland)
  • AbbVie Inc. (U.S.)
  • Arquer Diagnostics Ltd. (U.K.)
  • Illumina, Inc. (U.S.)
  • Qiagen (Germany)
  • Agilent Technologies (U.S.)
  • Merck & Co. Inc. (U.S.)
  • Becton Dickinson and Company (U.S.)
  • Hologic Inc. (U.S.))


$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
Single User $ 4,400.00
Multiple User $ 6,600.00
Corporate User $ 8,900.00
buy now spinner

Our Clients